Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

CHP MERGER CORP.

(CHPM)
Delayed Nasdaq  -  04:00 2022-04-22 pm EDT
10.18 USD   -0.10%
04/22CHP Merger Corp.(NasdaqCM:CHPM) dropped from NASDAQ Composite Index
CI
04/15Chp Merger : Accelus and CHP Merger Corp. Mutually Agree To Terminate Business Combination - Form 8-K
PU
04/15Chp Merger Corp. : Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsCompanyFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CHP MERGER CORP. : Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)

04/15/2022 | 04:50pm EST

Item 1.02. Termination of a Material Definitive Agreement.

As previously disclosed, on November 14, 2021, CHP Merger Corp., a Delaware corporation ("CHP" or the "Company"), entered into a business combination, by and among CHP, Accelerate Merger Sub, Inc., a wholly owned subsidiary of CHP ("Merger Sub"), and Integrity Implants Inc. d/b/a Accelus ("Accelus") (as amended on November 30, 2021 and December 23, 2021, as reported in CHP's Current Reports on Form 8-K filed with the U.S. Securities and Exchange Commission ("SEC") on December 6, 2021 and December 30, 2021, respectively, and as it may be further amended and/or restated from time to time, the "Business Combination Agreement").

Termination of Business Combination Agreement

On April 15, 2022, the Company, Merger Sub and Accelus entered into a Termination Agreement (the "Termination Agreement"), pursuant to which the parties agreed to mutually terminate the Business Combination Agreement. The termination of the Business Combination Agreement is effective as of April 15, 2022. Pursuant to the Termination Agreement, Accelus has agreed to pay the Company an aggregate of $3.5 million if, and only if, Accelus issues and sells (or receives binding commitments to purchase) shares of its preferred stock in exchange for aggregate gross proceeds actually received of at least $12 million (excluding amounts deemed received upon conversion of any convertible securities, and excluding any indebtedness) by May 2, 2022.

As a result of the termination of the Business Combination Agreement, the Business Combination Agreement and all Ancillary Agreements (as defined in the Business Combination Agreement) entered into in connection therewith are void and there is no liability under the Business Combination Agreement or any Ancillary Agreement on the part of any party thereto, except as set forth in the Termination Agreement, including, but not limited to, under the Sponsor Letter Agreement, dated November 14, 2021, as amended and restated on November 30, 2021, by and among CHP Acquisition Holdings, LLC, CHP and Accelus. Pursuant to the Termination Agreement, subject to certain exceptions, the Company and Accelus have also agreed, on behalf of themselves and their respective related parties, to a release of claims relating to the transactions contemplated under the Business Combination Agreement.

Accordingly, because the Company will not be able to complete a business combination by May 26, 2022, pursuant to the Company's amended and restated certificate of incorporation, the Company has determined to, as soon as practicable, liquidate and distribute to the holders of common stock issued in its initial public offering their pro-rata portion of the funds held in the trust account established for the benefit of such stockholders, which will be an amount equal to the aggregate amount on deposit in the trust account, including any amounts representing interest earned on the trust account then held therein, less any interest to be released to the Company to pay its franchise and income taxes (less up to $100,000 of such net interest to pay dissolution expenses). The Company's warrants will expire with no value. As provided for in the Company's Current Report on Form 8-K filed with the SEC on November 22, 2021, the Company will not fund a monthly contribution into the trust account on April 26, 2022.

The foregoing descriptions of the Business Combination Agreement and the Termination Agreement do not purport to be complete and are qualified in their entirety by the terms and conditions of the full text of the Business Combination Agreement, which was previously filed as Exhibit 2.1 to the Company's Current Report on Form 8-K, filed with the SEC on November 18, 2021, and the full text of the Termination Agreement, which is attached hereto as Exhibit 10.1, each of which is incorporated by reference herein.

Item 8.01. Other Events.

On April 15, 2022, the Company and Accelus issued a joint press release announcing the termination of the Business Combination Agreement. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

--------------------------------------------------------------------------------

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits

Exhibit
  No.                                     Description

10.1           Termination Agreement, dated April 15, 2022, by and among CHP Merger
             Corp., Accelerate Merger Sub, Inc. and Integrity Implants Inc. d/b/a
             Accelus

99.1           Press Release, dated April 15, 2022

104          Cover Page Interactive Data File (formatted as Inline XBRL)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about CHP MERGER CORP.
04/22CHP Merger Corp.(NasdaqCM:CHPM) dropped from NASDAQ Composite ..
CI
04/15Chp Merger : Accelus and CHP Merger Corp. Mutually Agree To Terminate Business Combination..
PU
04/15Chp Merger Corp. : Termination of a Material Definitive Agreement, Other Events, Financial..
AQ
04/15Accelus and CHP Merger Corp. Mutually Agree To Terminate Business Combination
AQ
04/15Integrity Implants Inc. cancelled the acquisition of CHP Merger Corp. from Concord Heal..
CI
03/21Chp Merger Corp. : Creation of a Direct Financial Obligation or an Obligation under an Off..
AQ
03/17CHP MERGER CORP. Management's Discussion and Analysis of Financial Condition and Resul..
AQ
03/17CHP Merger Corp. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/17CHP Merger Corp. Auditor Raises 'Going Concern' Doubt
CI
03/11Chp Merger Corp. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
More news